MORRISVILLE, N.C. (Business Wire) August 7th 2012 — Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, announced today the 20th year anniversary of its founding in Europe.

On August 1st, 1992 Kurt Pfister, Chief Executive Officer, European Operations, and Kathryn Voegeli, Chief Operating Officer, European Operations, founded PFC Pharma Focus AG in Switzerland. The company expanded its geographic footprint by founding affiliate companies in Germany, Israel and India and forming a network throughout Europe to conduct pan-European projects.

With the merger of PFC Pharma Focus AG and Clinipace Worldwide in 2011, the organizations formed a truly global dCRO with centralized North American, South American, and European hubs for strategic drug and medical device product development, clinical operations, data management, regulatory affairs, and GxP/CMC quality assurance. The European headquarters of Clinipace Worldwide shares the organization’s collective vision of helping emerging and mid-tier life science firms clients serve patients by substantially accelerating the drug and device development processes via technology-amplified services.

“I am very proud we succeeded in developing our company within these 20 years to a quality-driven, mid-sized CRO leveraging IT technology to be highly competitive in the market. Over our 20 years of operation, we have developed and fine-tuned our expertise to support any needs our customers may have across a multitude of therapeutic areas and indications,” said Kurt Pfister, CEO, European Operations, Clinipace Worldwide.

About Clinipace Worldwide
As a global full-service digital contract research organization (dCRO), we have pioneered an innovative technology-amplified research model to serve the unique needs of emerging and mid-tier biopharmaceutical and medical device firms. Powered by TEMPO™, our proprietary eClinical platform, our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies, clinical development, and post-approval research to ensure a successful drug and medical device development program. We have managed over 600 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Boulder, Overland Park, Zurich, Munich, Tel-Aviv, Sao Paulo, Buenos Aires, Lima, and New Delhi. For more information, visit our website at www.clinpace.com.